Newly appointed Valeant Pharmaceuticals International Inc. (NYSE: VRX) director Bill Ackman said that the board may name a new chief executive within weeks sending the stock price soaring $4.92 to $33.65.
Valeant Pharmaceuticals may name new CEO soon
April 06, 2016 at 11:56 AM EDT
